Antiproliferative, DNA intercalation and redox cycling activities of dioxonaphtho[2,3-d]imidazolium analogs of YM155: A structure–activity relationship study-Reference-Cited by-同舟云学术

Antiproliferative, DNA intercalation and redox cycling activities of dioxonaphtho[2,3-d]imidazolium analogs of YM155: A structure–activity relationship study

Published:2015-11 Issue: Volume:104 Page:42-56
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Ho Si-Han Sherman,Sim Mei-Yi,Yee Wei-Loong Sherman,Yang Tianming,Yuen Shyi-Peng John,Go Mei-Lin

Funder

National University of Singapore

SingHealth Foundation

Ministry of Education for provision of the National University of Singapore President Graduate Fellowship

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference51 articles.

1. Investigations of survivin: the past, present and future;Cheung;Front. Biosci.,2011

2. Expression of the antiapoptotic protein survivin in colon cancer;Hernandez;Clin. Colorectal Cancer,2011

3. Survivin: a new target for anti-cancer therapy;Ryan;Cancer Treat. Rev.,2009

4. Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics;Mita;Clin. Cancer Res.,2008

5. The inhibitor of apoptosis (IAP) survivin is expressed in human testicular germ cell tumors and normal testes;Weikert;Cancer Lett.,2004

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, crystals structures, DFT, and anticancer activities of polycyclic heterocyclic quinones;Journal of Molecular Structure;2024-08

2. Synthesis, Crystals Structures, Dft and Anticancer Activities of Polycyclic Heterocyclic Quinones;2024

3. Small Molecule Inhibitors Targeting the “Undruggable” Survivin: The Past, Present, and Future from a Medicinal Chemist’s Perspective;Journal of Medicinal Chemistry;2023-12-13

4. Pioneering 4,11-Dioxo-4,11-dihydro-1H-anthra[2,3-d]imidazol-3-ium Compounds as Promising Survivin Inhibitors by Targeting ILF3/NF110 for Cancer Therapy;Journal of Medicinal Chemistry;2023-12-11

5. Natural Products–Pyrazine Hybrids: A Review of Developments in Medicinal Chemistry;Molecules;2023-11-05